Murad Melhem

Murad Melhem possesses extensive experience in clinical pharmacology, particularly in the oncology sector. Currently serving as Executive Director at GSK since July 2020, Murad previously held the position of Senior Director at Vertex Pharmaceuticals and contributed as Principal Scientist at Amgen. A background in pharmacokinetics and pharmacokinetic-pharmacodynamic analyses features prominently in Murad's career, with significant leadership roles at the Institute for Clinical Pharmacodynamics and Eli Lilly & Company. Educational qualifications include a PhD in Pharmaceutical Sciences from the University of Cincinnati and a BSc in Pharmacy from the University of Jordan.